CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 136,806 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 40,000 shares at $4.50 ($180,000)
- 4 Open-market buy President and CEO bought 22,223 shares at $4.50 ($100,004)
- 4 Open-market buy Director bought 4,444 shares at $4.50 ($19,998)
- 4 Open-market buy Director bought 4,444 shares at $4.50 ($19,998)
- 4 Open-market buy Chief Financial Officer bought 3,333 shares at $4.50 ($14,999)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 893,025 shares at $4.50 ($4,018,613)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 23 of 33 · 650 filings